New 52 Week Low Today

WuXi Biologics (Cayman) Inc 2269-HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 4:08 PM CTT
12.44quote price arrow down-0.44 (-3.42%)
Volume
51,658,761
52 week range
12.40 - 52.45
Loading...
  • Open12.72
  • Day High12.92
  • Day Low12.40
  • Prev Close12.88
  • 52 Week High52.45
  • 52 Week High Date11/08/23
  • 52 Week Low12.40
  • 52 Week Low Date05/24/24

Key Stats

  • Market Cap7,679.54M
  • Shares Out4,260.84M
  • 10 Day Average Volume103.48M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change-57.97

KEY STATS

  • Open12.72
  • Day High12.92
  • Day Low12.40
  • Prev Close12.88
  • 52 Week High52.45
  • 52 Week High Date11/08/23
  • 52 Week Low12.40
  • 52 Week Low Date05/24/24
  • Market Cap7,679.54M
  • Shares Out4,260.84M
  • 10 Day Average Volume103.48M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change-57.97

RATIOS/PROFITABILITY

  • EPS (TTM)0.90
  • P/E (TTM)13.84
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On WuXi Biologics (Cayman) Inc

 

Profile

MORE
WuXi Biologics Cayman Inc is an investment holding company principally engaged in provision of discovery, development and manufacturing services of biologics. Through fully-integrated biologics Contract Research, Development and Manufacturing Organization (CRDMO), the Company provides one-stop end-to-end biologics services. Biologics development process stages include pre-IND (drug discovery and pre-clinical development), early-phase (phases I & II) clinical development...
Ge Li Ph.D.
Non-Executive Chairman of the Board
Zhisheng Chen
Chief Executive Officer, Executive Director
Ming Tu
Chief Financial Officer
Jijie Gu Ph.D.
Executive Vice President, Chief Scientific Officer
Address
No. 108, Meiliang Road, Mashan
Wuxi, JNG
China